P-MTAB-28453 - P-MTAB-28453

Type
specified_biomaterial_action
Description
Peripheral blood (PB) samples were obtained before (day -2, -1 or 0) and after (median day 6, range 2-7) the first administrations of DAC (given at a dose of 15 mg/m2, 3 times daily on 3 consecutive days) from eight elderly patients with newly diagnosed AML treated within a phase II trial of DAC
Links
Experiment E-MEXP-3737